Figure 9From: Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry Kaplan-Meier survival analysis by CD133, VM and MVD status (A is CD133; B is VM; C is MVD). (n=305). The y-axis represents the percentage of patients; the x-axis, their survival in months. The green line represents VM positive patients with a trend of worse survival than the blue line representing VM negative NSCLC patients (P<0.001). Mean survival times were 16.9 months for the VM positive group and 51.4 months for the VM negative group.Back to article page